This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: David J Schnepple: Innovator in Apoptosis Research
Introduction
David J Schnepple is a notable inventor based in Crofton, MD (US). He has made significant contributions to the field of apoptosis research, particularly through his innovative methods and materials aimed at modulating this critical biological process. His work is essential for understanding and treating conditions associated with apoptosis.
Latest Patents
David J Schnepple holds a patent titled "Methods of reducing trail-induced apoptosis by trail isoforms." This patent outlines methods and materials related to apoptosis, providing valuable insights into how to modulate this process. The document also discusses approaches for treating mammals that have conditions associated with apoptosis, showcasing the potential impact of his research on medical science.
Career Highlights
Schnepple is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in apoptosis. His work is characterized by a commitment to improving health outcomes through innovative scientific methods.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Andrew Badley and Gary D Bren. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
David J Schnepple's contributions to apoptosis research through his patent and work at the Mayo Foundation for Medical Education and Research highlight his role as an innovator in the medical field. His efforts are paving the way for new treatments and a deeper understanding of apoptosis-related conditions.